Business / Finance

RSS

Flamel first quarter total revenues increase to $7.3 million

Flamel Technologies today announced its financial results for the first quarter of 2012.

7 May 2012

BioCryst first quarter revenues increase to $12.2 million

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2012.

7 May 2012

Accellent to sell Pittsburgh facility to Perryman

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

5 May 2012

ViSalus first quarter 2012 sales increase to $136.7 million

ViSalus, the number one challenge marketing company with its Body by Vi 90-Day Challenge, today announced first quarter 2012 sales of $136.7 million compared to $20.0 million for the same period last year. The Company had over 92,000 independent Promoters at the end of the first quarter versus over 16,000 for the same period last year.

5 May 2012

Pro-Dex third quarter sales decrease 34% to $4.5 million

PRO-DEX, INC. today announced financial results for its fiscal third quarter and nine months ended March 31, 2012.

5 May 2012

American Anesthesiology acquires BAA

American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Brazos Anesthesiology Associates, P.A. (BAA), a physician group practice based in Bryan, Texas that provides anesthesia services, including cardiac, pediatric, obstetric, regional anesthesia and chronic pain management, throughout the Brazos Valley.

5 May 2012

MAP Pharmaceuticals first quarter net loss increases to $17.8 million

MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.

5 May 2012

Oxford closes term loan securitization transaction

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a term loan securitization transaction completed on April 26, 2012.

5 May 2012

Sirona second quarter revenue increases 8% to $231.9 million

Sirona, the dental technology leader, today announced its financial results for the quarter ended March 31, 2012.

5 May 2012

Cambrex first quarter sales increase 14.4% to $70.6 million

Cambrex Corporation reports first quarter results for the period ended March 31, 2012.

4 May 2012

NPS first quarter net loss increases to $10.6 million

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the first quarter of 2012.

4 May 2012

Alnylam first quarter revenues decrease to $20.6 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.

4 May 2012

NHC first quarter net income decreases 36.5% to $10,508,000

National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.

4 May 2012

Affymetrix total revenue decreases to $65.2 million

Affymetrix, Inc., today reported its operating results for the first quarter of 2012. Total revenue for the quarter was $65.2 million, as compared to total revenue of $73.7 million for the same period of 2011.

4 May 2012

Abbott to purchase AP214 hormone analogue from Action Pharma

Abbott and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.

4 May 2012

Addus HomeCare first quarter total revenues increase 16% to $67.9M

Addus HomeCare Corporation, a provider of home-based social and medical services focused primarily on the elderly dual eligible population, announced today its financial results for the three months ended March 31, 2012.

4 May 2012

SXC first quarter revenue increases 56% to $1.7 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month period ended March 31, 2012.

4 May 2012

PDL first quarter total revenues decrease to $77.3 million

PDL BioPharma, Inc. (PDL) today reported financial results for the first quarter ended March 31, 2012.

4 May 2012

Affymetrix to acquire eBioscience

Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.

4 May 2012